1 active not recruiting, 1 available, 1 not yet recruiting, 1 recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Recruiting 1 |
| Phase 2 | 2 | Active not recruiting 1, Recruiting 1 |
Follow Creative Medical Technology Holdings Inc: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Project PHOENIX: Molecular Signatures of Burn Pit Exposure Prior Burn Pit Exposure, No Known Burn Pit Exposure - Burn Pit Exposure, Airborne Hazard Exposure | Not yet recruiting | Creative Medical Technology Holdings Inc | 1000 | 2026-05-01 | 2026-05-01 | |
| Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Back Pain CELZ-201-DDT, Placebo - Chronic Low-back Pain, Degenerative Disc Disease | Phase 1 / Phase 2 | Active not recruiting | Creative Medical Technology Holdings Inc | 45 | 2024-05-21 | 2026-08-21 |
| Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes CELZ-201 Administration, Control Group - Type 1 Diabetes, Diabetes Mellitus, Type 1 | Phase 1 / Phase 2 | Recruiting | Creative Medical Technology Holdings Inc | 18 | 2023-04-07 | 2026-02-19 |
| CELZ-201-DDT for the Treatment of Chronic Lower Back Pain CELZ-201-DDT - Chronic Back Pain, Degenerative Disc Disease Lumbar | Available | Creative Medical Technology Holdings Inc | 2025-08-22 |
Intervertebral Disc Degeneration (2) · Chronic Pain (1) · Diabetes Mellitus, Type 1 (1) · Immune System Diseases (1) · Signs and Symptoms, Respiratory (1)
Control Groups (1)
United States (2)